Immatics N.V. (IMTX)

Harpreet Singh-Jasuja
49 7071 5397 700

Immatics N.V. focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. Its ACTengine product candidates are in Phase I clinical trials, which include IMA201 that targets melanoma-associated antigen 4 or 8 in patients with solid tumors. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited.

Data derived from most recent annual or quarterly report
Market Cap 523.4 Million Shares Outstanding62.909 Million Avg 30-day Volume 617.357 Thousand
P/E Ratio16.6399 Dividend Yield0.0 EPS-1.48
Price to Revenue3.6118 Debt to Equity0.0683 EBITDA52.451 Million
Price to Book Value2.9284 Operating Margin17.3314 Enterprise Value524.495 Million
Current Ratio4.316 EPS Growth1.372 Quick Ratio1.712
1 Yr BETA 1.0045 52-week High/Low 13.14 / 5.9 Profit Margin21.7056
Operating Cash Flow Growth211.6818 Free Cash Flow to Firm (FCFF) TTM -168.275 Million Free Cash Flow to Equity (FCFE) TTM
Altman Z-Score1.8234

Are you looking for this stock instead?

Funds Holding IMTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)


Open Market Sells (S)


Exercise Derivative Conversion (M)


Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
IMMATICS NV IMTX 2021-02-26 18:45:03 UTC -1.9529 2.0229 300000
IMMATICS NV IMTX 2021-02-26 18:15:02 UTC -1.9529 2.0229 300000
IMMATICS NV IMTX 2021-02-26 17:45:02 UTC -1.9529 2.0229 300000
IMMATICS NV IMTX 2021-02-26 17:15:03 UTC -1.9529 2.0229 300000
IMMATICS NV IMTX 2021-02-26 16:45:03 UTC -2.5234 2.5934 300000
IMMATICS NV IMTX 2021-02-26 16:15:02 UTC -2.5234 2.5934 300000
IMMATICS NV IMTX 2021-02-26 15:45:03 UTC -2.5234 2.5934 300000
IMMATICS NV IMTX 2021-02-26 15:15:03 UTC -2.5234 2.5934 300000
IMMATICS NV IMTX 2021-02-26 14:45:03 UTC -2.3733 2.4433 300000
IMMATICS NV IMTX 2021-02-26 13:00:03 UTC -2.3733 2.4433 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments